These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2393768)
1. A new protocol for the treatment of stage I cutaneous malignant melanoma; interim results of the first 806 patients treated. Evans J; McCann BG Br J Plast Surg; 1990 Jul; 43(4):426-30. PubMed ID: 2393768 [TBL] [Abstract][Full Text] [Related]
2. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report. Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A; Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753 [TBL] [Abstract][Full Text] [Related]
3. Melanoma of the ear: prognostic factors and surgical strategies. Jahn V; Breuninger H; Garbe C; Moehrle M Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802 [TBL] [Abstract][Full Text] [Related]
4. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910 [TBL] [Abstract][Full Text] [Related]
5. Excision versus incision biopsy in the management of malignant melanoma. Sharma KS; Lim P; Brotherston MT J Dermatolog Treat; 2016; 27(1):88-90. PubMed ID: 25886086 [TBL] [Abstract][Full Text] [Related]
6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
7. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery. Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440 [TBL] [Abstract][Full Text] [Related]
8. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence. Gad D; Høilund-Carlsen PF; Bartram P; Clemmensen O; Bischoff-Mikkelsen M J Surg Oncol; 2006 Aug; 94(2):94-100. PubMed ID: 16847917 [TBL] [Abstract][Full Text] [Related]
9. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Griffiths RW; Briggs JC Ann R Coll Surg Engl; 1985 Mar; 67(2):75-8. PubMed ID: 3977262 [TBL] [Abstract][Full Text] [Related]
10. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
11. Delay of Surgery for Melanoma Among Medicare Beneficiaries. Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865 [TBL] [Abstract][Full Text] [Related]
12. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678 [TBL] [Abstract][Full Text] [Related]
14. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Gupta TK Ann Surg; 1977 Aug; 186(2):201-9. PubMed ID: 889365 [TBL] [Abstract][Full Text] [Related]
15. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. McKenna DB; Lee RJ; Prescott RJ; Doherty VR Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337 [TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Wanebo HJ; Woodruff J; Fortner JG Cancer; 1975 Mar; 35(3):666-76. PubMed ID: 1111935 [TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Moxley KM; Fader AN; Rose PG; Case AS; Mutch DG; Berry E; Schink JC; Kim CH; Chi DS; Moore KN Gynecol Oncol; 2011 Sep; 122(3):612-7. PubMed ID: 21570710 [TBL] [Abstract][Full Text] [Related]
19. Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Group. Thornes D; Daly L; Lynch G; Browne H; Tanner A; Keane F; O'Loughlin S; Corrigan T; Daly P; Edwards G Eur J Surg Oncol; 1989 Oct; 15(5):431-5. PubMed ID: 2676609 [TBL] [Abstract][Full Text] [Related]
20. Early recurrence in sentinel lymph node positive stage III melanoma patients. Baker JJ; Ollila DW; Deal AM; Frank J; Amos KD; Meyers MO Am Surg; 2012 Jul; 78(7):808-13. PubMed ID: 22748543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]